BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28286260)

  • 1. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing LncRNA LOXL1-AS1 attenuates mesenchymal characteristics of glioblastoma via NF-κB pathway.
    Wang H; Li L; Yin L
    Biochem Biophys Res Commun; 2018 Jun; 500(2):518-524. PubMed ID: 29678575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway.
    Cai J; Zhang J; Wu P; Yang W; Ye Q; Chen Q; Jiang C
    J Neurooncol; 2018 Nov; 140(2):225-236. PubMed ID: 30043319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma.
    Zeng A; Yin J; Li Y; Li R; Wang Z; Zhou X; Jin X; Shen F; Yan W; You Y
    Cell Death Dis; 2018 Mar; 9(3):394. PubMed ID: 29531296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways.
    Huang T; Alvarez AA; Pangeni RP; Horbinski CM; Lu S; Kim SH; James CD; J Raizer J; A Kessler J; Brenann CW; Sulman EP; Finocchiaro G; Tan M; Nishikawa R; Lu X; Nakano I; Hu B; Cheng SY
    Nat Commun; 2016 Oct; 7():12885. PubMed ID: 27698350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma.
    Singh A; Srivastava N; Yadav A; Ateeq B
    Neoplasia; 2020 Oct; 22(10):497-510. PubMed ID: 32896760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.
    Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS
    Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.
    Wang H; Tao T; Yan W; Feng Y; Wang Y; Cai J; You Y; Jiang T; Jiang C
    Sci Rep; 2015 Aug; 5():13072. PubMed ID: 26283154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
    Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J
    Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma.
    Zhang C; Han X; Xu X; Zhou Z; Chen X; Tang Y; Cheng J; Moazzam NF; Liu F; Xu J; Peng W; Du F; Zhang B; Song Z; Zeng J; Gong A
    Cell Death Dis; 2018 May; 9(5):469. PubMed ID: 29700308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
    Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
    Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
    Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
    Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathway.
    Lu F; Li C; Sun Y; Jia T; Li N; Li H
    World J Surg Oncol; 2020 Jun; 18(1):147. PubMed ID: 32605563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
    Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
    Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
    Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
    Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.
    Khalil S; Fabbri E; Santangelo A; Bezzerri V; Cantù C; Di Gennaro G; Finotti A; Ghimenton C; Eccher A; Dechecchi M; Scarpa A; Hirshman B; Chen C; Ferracin M; Negrini M; Gambari R; Cabrini G
    Oncotarget; 2016 May; 7(19):28195-206. PubMed ID: 27057640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.
    Wang R; Zhang S; Chen X; Li N; Li J; Jia R; Pan Y; Liang H
    Mol Cancer; 2018 Nov; 17(1):166. PubMed ID: 30470262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.